Autoimmune pancreatitis epidemiology and demographics

	Autoimmune pancreatitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Autoimmune pancreatitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Guidelines for Management
Case Studies
Case #1
Autoimmune pancreatitis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Autoimmune pancreatitis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Autoimmune pancreatitis epidemiology and demographics
CDC on Autoimmune pancreatitis epidemiology and demographics
Autoimmune pancreatitis epidemiology and demographics in the news
Blogs on Autoimmune pancreatitis epidemiology and demographics
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Autoimmune pancreatitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]

Overview

Autoimmune pancreatitis is a world wide entitiy but it's incidence has been found to be recently increased in Japan.^[1]^[2]^[3]

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
The case-fatality rate/mortality rate of [disease name] is approximately [number range].

There is no racial predilection to [disease name].
[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

↑ Finkelberg DL, Sahani D, Deshpande V, Brugge WR (2006). "Autoimmune pancreatitis". N. Engl. J. Med. 355 (25): 2670–6. doi:10.1056/NEJMra061200. PMID 17182992.
↑ Okazaki K (2003). "Autoimmune pancreatitis is increasing in Japan". Gastroenterology. 125 (5): 1557–8. PMID 14628815.
↑ Kim KP, Kim MH, Lee SS, Seo DW, Lee SK (2004). "Autoimmune pancreatitis: it may be a worldwide entity". Gastroenterology. 126 (4): 1214. PMID 15057766.
↑ Okazaki K, Uchida K, Chiba T (2001). "Recent concept of autoimmune-related pancreatitis". J. Gastroenterol. 36 (5): 293–302. PMID 11388391.
↑ Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K (2002). "ERCP features in 27 patients with autoimmune pancreatitis". Gastrointest. Endosc. 55 (4): 494–9. PMID 11923760.
↑ Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K, Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K (2002). "HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population". Gastroenterology. 122 (5): 1264–9. PMID 11984513.